Drug intelligence / Profile preview

amorolfine (Resilient Cosmeceuticals Pvt. Ltd.)

Development stage
Unknown
Lead developer
Resilient Cosmeceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Amfun Cream is a topical antifungal medication containing the active ingredient amorolfine. Developed by Resilient Cosmeceuticals, it is approved for the treatment of dermatophytoses, which are fungal infections of the skin such as ringworm, athlete's foot, and jock itch. Amorolfine belongs to the morpholine class of antifungals and works by interfering with the biosynthesis of ergosterol, a vital component of fungal cell membranes. It specifically inhibits two enzymes: sterol delta-14-reductase and cholestenol delta-isomerase. This dual inhibition leads to the depletion of ergosterol and the accumulation of atypical sterols, resulting in structural and functional changes in the fungal cell membrane and ultimately cell death.

Brand names
Amfun Cream
Other names
Amfunamorolfine hydrochloride
02

Targets

EBP (Sterol isomerase (emopamil-binding protein))SQLE (Squalene monooxygenase)TM7SF2 (Sterol 14-reductase)

Beyond the preview

Go deeper on amorolfine (Resilient Cosmeceuticals Pvt. Ltd.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amorolfine (Resilient Cosmeceuticals Pvt. Ltd.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call